Myovant Sciences's average Accounts Receivable for the
three
months ended in Mar. 2022 was $21.1 Mil. Myovant Sciences's Revenue for the
three
months ended in Mar. 2022 was $57.6 Mil.
Hence, Myovant Sciences's Days Sales Outstanding for the
three
months ended in Mar. 2022 was 33.45.
The historical rank and industry rank for Myovant Sciences's Days Sales Outstanding or its related term are showing as below:
MYOV'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.23 Med: 21.6 Max: 22.37
Current: 22.37
During the past 7 years, Myovant Sciences's highest Days Sales Outstanding was 22.37. The lowest was 21.23. And the median was 21.60.
MYOV's Days Sales Outstanding is ranked better than 89.06% of 887
companies
in the Biotechnology industry
Industry Median: 69.19
vs MYOV: 22.37
Myovant Sciences's Days Sales Outstanding
increased
from Mar. 2021 (13.24) to Mar. 2022 (33.45).
Myovant Sciences Days Sales Outstanding Historical Data
The historical data trend for Myovant Sciences's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Myovant Sciences Annual Data
Trend
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Days Sales Outstanding
-
-
-
21.97
21.23
Myovant Sciences Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Days Sales Outstanding
13.24
15.75
14.65
27.92
33.45
Competitive Comparison
For the Biotechnology subindustry, Myovant Sciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Myovant Sciences Days Sales Outstanding Distribution
For the Biotechnology industry and Healthcare sector, Myovant Sciences's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Myovant Sciences's Days Sales Outstanding falls into.
Myovant Sciences Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Myovant Sciences (NYSE:MYOV) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Myovant Sciences Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Myovant Sciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Myovant Sciences Ltd is a healthcare company focused on redefining care for women and for men. The company's lead product candidate is relugolix, a once-daily, oral GnRH receptor antagonist. It has three late-stage clinical programs for relugolix in uterine fibroids, endometriosis, and prostate cancer. The company is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, that has completed a Phase 2a study for the treatment of female infertility as part of assisted reproduction.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.81(8.08%) Volume: 603,321 4:01PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MYOV has been successfully added to your 
